Review



voxilaprevir hcv ns3 4a protease inhibitor chronic hcv after selected prior daa failure us fda approved in the fixed dose vosevi rescue regimen  (Gilead Sciences)

 
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Gilead Sciences voxilaprevir hcv ns3 4a protease inhibitor chronic hcv after selected prior daa failure us fda approved in the fixed dose vosevi rescue regimen
    Chemical structures, molecular targets, and regulatory status of small‐molecule antivirals.
    Voxilaprevir Hcv Ns3 4a Protease Inhibitor Chronic Hcv After Selected Prior Daa Failure Us Fda Approved In The Fixed Dose Vosevi Rescue Regimen, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 178 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/selection/Vosevi/pmc13748950-6-0-17
    Average 97 stars, based on 178 article reviews
    voxilaprevir hcv ns3 4a protease inhibitor chronic hcv after selected prior daa failure us fda approved in the fixed dose vosevi rescue regimen - by Bioz Stars, 2026-11
    97/100 stars

    Images

    1) Product Images from "Therapeutic and Prophylactic Agents for Viral Diseases: Current Status, Challenges, and Future Prospects"

    Article Title: Therapeutic and Prophylactic Agents for Viral Diseases: Current Status, Challenges, and Future Prospects

    Journal: MedComm

    doi: 10.1002/mco2.71024

    Chemical structures, molecular targets, and regulatory status of small‐molecule antivirals.
    Figure Legend Snippet: Chemical structures, molecular targets, and regulatory status of small‐molecule antivirals.

    Techniques Used: Protease Inhibitor

    Related Articles

    Virus:

    Article Title: Hepatitis C Virus Elimination: So Close, So Far?
    Article Snippet: 21 22 The advent of highly effective direct-acting antivirals (DAAs) has transformed hepatitis 23 C virus (HCV) infection into a curable disease, with cure rates exceeding 95% across viral 24 genotypes and clinical settings.. Along with simplified, short-course treatment regimens and 25 significant advancements in diagnostic technologies, these therapeutic breakthroughs have 26 made eliminating HCV as a public health concern, as defined by the World Health 27 Organization, a realistic goal.. However, despite this progress, global advances toward 28 elimination have fallen short of expectations.

    Protease Inhibitor:

    Article Title: Hepatitis C Virus Elimination: So Close, So Far?
    Article Snippet: 21 22 The advent of highly effective direct-acting antivirals (DAAs) has transformed hepatitis 23 C virus (HCV) infection into a curable disease, with cure rates exceeding 95% across viral 24 genotypes and clinical settings.. Along with simplified, short-course treatment regimens and 25 significant advancements in diagnostic technologies, these therapeutic breakthroughs have 26 made eliminating HCV as a public health concern, as defined by the World Health 27 Organization, a realistic goal.. However, despite this progress, global advances toward 28 elimination have fallen short of expectations.

    Article Title: Therapeutic and Prophylactic Agents for Viral Diseases: Current Status, Challenges, and Future Prospects
    Article Snippet: Sofosbuvir Nucleotide prodrug; HCV NS5B polymerase inhibitor; chronic HCV; US FDA‐approved alone and in fixed‐dose DAA combinations , C 22 H 29 FN 3 O 9 P; CID 45375808 , Velpatasvir HCV NS5A inhibitor; chronic HCV; US FDA‐approved with sofosbuvir (Epclusa) and in sofosbuvir/velpatasvir/voxilaprevir (Vosevi) , C 49 H 54 N 8 O 8 ; CID 67683363. .. Voxilaprevir HCV NS3/4A protease inhibitor; chronic HCV after selected prior DAA failure; US FDA‐approved in the fixed‐dose Vosevi rescue regimen , C 40 H 52 F 4 N 6 O 9 S; CID 89921642 , Nirmatrelvir Covalent reversible SARS‐CoV‐2 Mpro/3CLpro inhibitor; COVID‐19; US FDA‐approved for eligible high‐risk adults only as nirmatrelvir/ritonavir (Paxlovid); pediatric use remains under EUA , C 23 H 32 F 3 N 5 O 4 ; CID 155903259. ..

    other:


    Article Title: Prenatal testing and postpartum treatment for hepatitis C virus among women with opioid use disorder
    Article Snippet: Sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg oral tablet [Vosevi] , 1939335.



    Similar Products

    90
    Thermo Fisher orion calcium-selective electrode
    Orion Calcium Selective Electrode, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/selection/10__22175_slash_mmb__17760-93-36-46
    Average 90 stars, based on 1 article reviews
    orion calcium-selective electrode - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Agilent technologies 5975-mass selection detector
    5975 Mass Selection Detector, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/selection/10__22175_slash_mmb__17751-111-18-21
    Average 90 stars, based on 1 article reviews
    5975-mass selection detector - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher calcium-selective electrode
    Calcium Selective Electrode, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/selection/calcium+selective+electrode/10__22175_slash_mmb__17760-93-38-46
    Average 90 stars, based on 1 article reviews
    calcium-selective electrode - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    94
    Thermo Fisher amphotericin b
    Amphotericin B, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/selection/Oxoid+CCDA+Selective+Supplement/pmc13636059-214-25-27
    Average 94 stars, based on 1 article reviews
    amphotericin b - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    R&D Systems fetal bovine serum
    Fetal Bovine Serum, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/selection/Fetal+Bovine+Serum+-+Premium+Select%2C+Heat+Inactivated/pmc13754023-237-29-33
    Average 95 stars, based on 1 article reviews
    fetal bovine serum - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    99
    InvivoGen puromycin selection
    Puromycin Selection, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/selection/Puromycin/pm42976857-256-13-17
    Average 99 stars, based on 1 article reviews
    puromycin selection - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Zymo Research dna clean and concentrator kit
    Dna Clean And Concentrator Kit, supplied by Zymo Research, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/selection/Select-a-Size+DNA+Clean+%26+Concentrator+Kit/pmc13748974-47-25-30
    Average 99 stars, based on 1 article reviews
    dna clean and concentrator kit - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    92
    MedChemExpress selective gsk 3α β inhibitors brd0705 cat
    Selective Gsk 3α β Inhibitors Brd0705 Cat, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/selection/BRD0705/pmc13746373-59-0-18
    Average 92 stars, based on 1 article reviews
    selective gsk 3α β inhibitors brd0705 cat - by Bioz Stars, 2026-11
    92/100 stars
      Buy from Supplier

    97
    Gilead Sciences voxilaprevir hcv ns3 4a protease inhibitor chronic hcv after selected prior daa failure us fda approved in the fixed dose vosevi rescue regimen
    Chemical structures, molecular targets, and regulatory status of small‐molecule antivirals.
    Voxilaprevir Hcv Ns3 4a Protease Inhibitor Chronic Hcv After Selected Prior Daa Failure Us Fda Approved In The Fixed Dose Vosevi Rescue Regimen, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/selection/Vosevi/pmc13748950-6-0-17
    Average 97 stars, based on 1 article reviews
    voxilaprevir hcv ns3 4a protease inhibitor chronic hcv after selected prior daa failure us fda approved in the fixed dose vosevi rescue regimen - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    99
    Gilead Sciences narrow selectivity margin between fungal and host membrane sterols
    Previously abandoned antimicrobial agents: historical role, cause of decline, current status, and nanotechnology‐relevant design requirements.
    Narrow Selectivity Margin Between Fungal And Host Membrane Sterols, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/selection/AmBisome/pmc13746107-7-54-80
    Average 99 stars, based on 1 article reviews
    narrow selectivity margin between fungal and host membrane sterols - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    Chemical structures, molecular targets, and regulatory status of small‐molecule antivirals.

    Journal: MedComm

    Article Title: Therapeutic and Prophylactic Agents for Viral Diseases: Current Status, Challenges, and Future Prospects

    doi: 10.1002/mco2.71024

    Figure Lengend Snippet: Chemical structures, molecular targets, and regulatory status of small‐molecule antivirals.

    Article Snippet: Voxilaprevir HCV NS3/4A protease inhibitor; chronic HCV after selected prior DAA failure; US FDA‐approved in the fixed‐dose Vosevi rescue regimen , C 40 H 52 F 4 N 6 O 9 S; CID 89921642 , Nirmatrelvir Covalent reversible SARS‐CoV‐2 Mpro/3CLpro inhibitor; COVID‐19; US FDA‐approved for eligible high‐risk adults only as nirmatrelvir/ritonavir (Paxlovid); pediatric use remains under EUA , C 23 H 32 F 3 N 5 O 4 ; CID 155903259.

    Techniques: Protease Inhibitor

    Previously abandoned antimicrobial agents: historical role, cause of decline, current status, and nanotechnology‐relevant design requirements.

    Journal: BioMed Research International

    Article Title: Nanotechnology as a Catalyst for Reintroducing Abandoned or Therapeutically Constrained Antimicrobial Agents: Opportunities and Translational Challenges

    doi: 10.1155/bmri/9486547

    Figure Lengend Snippet: Previously abandoned antimicrobial agents: historical role, cause of decline, current status, and nanotechnology‐relevant design requirements.

    Article Snippet: Amphotericin B – polyene , Isolated from Streptomyces nodosus ; introduced clinically in the late 1950s and remained the principal broad‐spectrum systemic antifungal for several decades (gold standard) despite severe infusion‐related toxicity. , Residual affinity for mammalian cholesterol alongside its target, fungal ergosterol, forms pores in renal tubular membranes at clinically active doses. , Narrow selectivity margin between fungal and host membrane sterols. , Retained as first‐line systemic therapy for invasive fungal infection, but almost exclusively in lipid‐based/liposomal formulations (e.g., AmBisome) that have already substantially reduced, though not eliminated, nephrotoxicity since the 1990s. , Further refinement of lipid‐based reformulation—the clearest existing proof‐of‐concept that nanocarrier encapsulation can rescue an abandoned‐by‐toxicity agent, and a template for other agents in this table. , [ ]; [ ]; [ ]; [ ] .

    Techniques: Nanotechnology, Isolation, Infection, Activity Assay, Toxicity, Membrane, Preserving, Tissue, Concentration Assay, Glycoproteomics, Purification, Filtration, Encapsulation, Formulation, Bacteria, Ointment, In Vitro, Produced